Catalyst Wire Dossier Catalyst Wire Dossier

Prismocitrate 18/0

citrate-containing replacement fluid for CVVHDF
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Prismocitrate 18/0, covering 2014-12-03 to 2014-12-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study on the Efficacy and Safety of Continuous Renal Replacement Therapy (CVVHDF) Using a Commercial Citrate-containing Replacement Fluid (Prismocitrate 18/0) [NA]

See pricing